Black Rock Inc. Trevena Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $505 - $315,700	-3,157 Reduced 0.11%	2,807,917 $430,000
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.5 $1.62 Million - $4.04 Million	-8,082,492 Reduced 74.2%	2,811,074 $1.16 Million
Q1 2022 May 12, 2022	SELL	$0.41 - $0.63 $100,816 - $154,912	-245,893 Reduced 2.21%	10,893,566 $5.99 Million
Q4 2021 Feb 10, 2022	BUY	$0.57 - $1.29 $6,136 - $13,888	10,766 Added 0.1%	11,139,459 $6.49 Million
Q3 2021 Nov 09, 2021	SELL	$1.11 - $1.7 $53,792 - $82,385	-48,462 Reduced 0.43%	11,128,693 $13.7 Million
Q2 2021 Aug 11, 2021	BUY	$1.46 - $2.25 $16.3 Million - $25.1 Million	11,177,155 New	11,177,155 $18.9 Million

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.